The state of Oklahoma has reached a $270 million agreement with Purdue Pharma—the makers of OxyContin—settling a lawsuit that claimed the company contributed to the deaths of thousands of Oklahoma residents by downplaying the risk of opioid addiction and overstating the drug’s benefits. As part of the settlement, more than $100 million will fund a new addiction treatment and research center at Oklahoma State University in Tulsa. This is the first settlement Purdue has made amid some 2,000 additional lawsuits connecting its painkiller OxyContin to the opioid crisis. After headlines, we’ll spend the rest of the hour looking at the opioid crisis.